Kopin Corporation — Q1 2023 Form 10-Q
Business context and period. Kopin develops and sells miniature displays, optical lenses, modules and related technology licenses for defense, industrial, consumer and other applications. This unaudited report covers the three months ended April 1, 2023; comparisons are to the three months ended March 26, 2022. Interim results may not indicate full-year performance.
Financial results and liquidity
| Metric | Q1 2023 | Comparable 2022 period |
|---|---|---|
| Total revenue | $10.76 million | $11.58 million |
| Operating loss | $2.83 million | $6.08 million |
| Net loss attributable to Kopin | $2.63 million; $0.03 per share | $1.37 million; $0.02 per share |
| Net cash used in operations | $4.17 million | $2.28 million |
- Product revenue was $7.65 million, up about 18%; R&D revenue was $2.90 million, down about 41%. Total revenue declined about 7%.
- Product gross profit was approximately $1.03 million, or about 13.5% of product revenue, versus a gross loss of approximately $1.28 million, or about negative 19.6%, in the comparable period. The filing attributes the improvement mainly to about $450,000 lower material costs for warranty issues.
- Cash and cash equivalents were $8.58 million and marketable debt securities were $21.03 million at April 1, 2023, totaling $29.61 million, versus $12.65 million at year-end 2022. Working capital was $35.0 million, up from $16.4 million.
- Investing cash outflow was $16.84 million, mainly reflecting purchases of marketable debt securities; financing cash inflow was $21.34 million from the equity and pre-funded warrant offering. Cash ended the quarter at $8.58 million.
- Total liabilities were $16.63 million. The balance sheet reports no conventional borrowing balance; operating lease liabilities totaled $3.17 million.
Material changes and notable items
- Defense application revenue rose to $6.42 million from $4.76 million, primarily on higher pilot-helmet display revenue. Industrial revenue fell to $0.93 million from $1.53 million, primarily due to lower headset sales. Consumer revenue increased to $0.31 million from $0.22 million.
- R&D expense fell to $2.31 million from $5.41 million, reflecting lower U.S. defense program spending, programs moving into production, and the transfer of OLED-related activity and employees to Lightning Silicon Technology (LST). SG&A increased to $4.65 million, including approximately $495,000 of credit-loss expense related to OLED receivables.
- The 2022 comparable-period net loss benefited from a $4.7 million unrealized investment gain, which did not recur. This helps explain why net loss increased despite the smaller operating loss.
- In January 2023, Kopin sold 17 million common shares and pre-funded warrants for up to 6 million additional shares. Gross proceeds were approximately $22.9 million; net proceeds were approximately $21.3–$21.4 million. The equity raise increased liquidity but also creates potential dilution.
- Kopin acquired the remaining 20% interest in eMDT during the quarter; eMDT is now wholly owned. Under agreements with LST, Kopin transferred certain OLED technology rights, customer development contracts and receivables. It received an 18 million-share preferred interest assessed at zero fair value, plus potential royalties; the shares carry no voting rights to elect LST’s board. Former senior executives and approximately 20 employees joined LST.
Outlook, risks and contingencies
- Management believes existing cash and cash equivalents are sufficient for current operating plans for at least 12 months from issuance of the financial statements, but gives no assurance. If results fall short or more liquidity is needed, Kopin may pursue equity financing, reduce expenses or seek a strategic transaction.
- Expected 2023 capital expenditures are $1 million to $2 million. The company expects R&D spending on display products, overlay weapon sights and OLED technologies, while continuing to invest in R&D despite losses.
- Remaining performance obligations were $17.5 million, which Kopin expects to recognize over the next 12 months; these are government contracts and are subject to cancellation.
- Risks highlighted include semiconductor and raw-material availability, customer requalification constraints for alternate components, the ability to grow revenue and achieve positive cash flow and profitability, retaining experienced personnel, and foreign-exchange exposure. Kopin does not hedge currency exposure.
- BlueRadios litigation remains pending, with trial scheduled for January 22–February 5, 2024. Kopin did not consider a loss probable and recorded no accrual; the amount of any potential loss is not clear from the filing.
- The company reported no material change in its risk-factor assessment from its 2022 Form 10-K. Management concluded disclosure controls were effective as of April 1, 2023.
Important facts for investors to verify
- Whether defense revenue growth and programs transitioning to production can offset weaker R&D and industrial demand.
- Cash burn and operating progress against management’s stated 12-month liquidity assessment, including whether additional capital is needed.
- Potential dilution from the 6 million pre-funded warrants and the terms and exercise status of those warrants.
- Collectability of OLED-related receivables and the basis for the $495,000 credit-loss expense and $800,000 receivables allowance.
- Cancellation risk and timing of the $17.5 million remaining performance obligations, as well as the potential value of LST royalties and the litigation exposure in the BlueRadios case.